>Specialists share insights on diagnostic tools, prospects for neuroprotective therapies, and the risk of MS.
Recently presented findings in AD have clinical implications now and in the long-term.
As the details of healthcare reform take shape, an ASP may provide a cost-efficient way for clinicians to go d...
>Some sleep problems occur with great frequency in women, while others present with greater intensity. Here’s...
From optimizing the benefits of paper calendars to embracing new electronic technologies, neurologists can gat...
Trauma or other brain deficits can impact the patient’s ability to recognize and respond to humor.
The newest formulation of botulinum toxin type A expands the treatment menu.
New oral agents—approved and in the pipeline—may instigate an evolution in the treatment of MS.
News // FDA Paralyzing Free Speech, Allergan Says
When the issue of freedom of speech enters the debate in the US, usually publishers or protestors come to mind, not Big Pharma. But a new lawsuit announced October 1 and brought by Allergan is cla...
Some sleep problems occur with great frequency in women, while others present with greater intensity. Here’s what you need to know. more >
Specialists share insights on diagnostic tools, prospects for neuroprotective therapies, and the risk of MS. more >
The changes proposed in Congress could mean big changes to your practice. We take a look at how things could play out. more >
Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.